Format

Send to

Choose Destination
See comment in PubMed Commons below
Theranostics. 2013 Aug 10;3(9):650-7. doi: 10.7150/thno.6668. eCollection 2013.

Label-free luminescent mesoporous silica nanoparticles for imaging and drug delivery.

Author information

1
1. Department of Chemistry and Bio-Imaging Research Center (BIRC), University of Georgia, Athens, GA 30602, United States;

Abstract

We report herein a straightforward and label-free approach to prepare luminescent mesoporous silica nanoparticles. We found that calcination at 400 °C can grant mesoporous organosilica nanoparticles with strong fluorescence of great photo- and chemical stability. The luminescence is found to originate from the carbon dots generated from the calcination, rather than the defects in the silica matrix as was believed previously. The calcination does not impact the particles' abilities to load drugs and conjugate to biomolecules. In a proof-of-concept study, we demonstrated that doxorubicin (Dox) can be efficiently encapsulated into these fluorescent mesoporous silica nanoparticles. After coupled to c(RGDyK), the nanoconjugates can efficiently home to tumors through interactions with integrin αvβ3 overexpressed on the tumor vasculature. This calcination-induced luminescence is expected to find wide applications in silica-based drug delivery, nanoparticle coating, and immunofluorescence imaging.

KEYWORDS:

Bioimaging; Doxorubicin.; Drug delivery; Integrin αvβ3; Silica nanoparticles

PMID:
24052805
PMCID:
PMC3776216
DOI:
10.7150/thno.6668
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Ivyspring International Publisher Icon for PubMed Central
    Loading ...
    Support Center